Amarin Corp Plc (AMRN)

[yellow_bluff]

or said another way, by the time exclusivity ends, vascepa should have such scale volume in terms of supply, it is unlikely that generics would be able to even compete on price. while v could lose market share due to new entrants, it seems less likely they would lose market share on price alone...